Markets
-
Gree’s “Cooker vs. Soup” Controversy: Dong Mingzhu Interrupts Livestream, Clarifies Criticism
Dong Mingzhu, chairwoman of Gree Electric, inaugurated a new store in Zhengzhou. During a live product demonstration, she interrupted a sales associate’s comment about a soup pot, emphasizing the importance of focusing on product details. Dong, known for her directness, explained this wasn’t criticism but a focus on excellence, a sentiment seemingly supported by the audience.
-
Celanese to Join Fireside Chat at Deutsche Bank’s 16th Annual Global Industrials and Materials Conference
Celanese Corporation (CE) will participate in the Deutsche Bank Global Industrials and Materials Conference. President and CEO Scott Richardson will present a fireside chat on June 5, 2025, at 11:50 AM ET. A live webcast and replay (available for a year) will be accessible on the Celanese Investor Relations website. Celanese is a global specialty materials and chemicals leader, employing over 11,000 people and with $10.3 billion in 2024 net sales.
-
SK Hynix Overtakes Samsung, Becomes World’s Largest DRAM Producer in Q1
SK Hynix has surpassed Samsung to become the world’s largest DRAM revenue generator in Q1 2025, fueled by high bandwidth memory (HBM) demand. A report from Omdia shows SK Hynix generated $9.718 billion in revenue, securing a 36% market share and dethroning Samsung, which held the top spot since 1992. Although a slight decrease from Q4 2024, SK Hynix’s performance highlights the shifting dynamics in the DRAM market.
-
US Imposes Travel Restrictions on 19 Countries, Including 12 with Complete Bans
The Trump administration implemented new travel restrictions targeting 19 countries, citing concerns about border security and visa overstays. Twelve nations face a complete entry ban, while seven others have partial restrictions. These measures, part of the “Make America Great Again” agenda, are likely to face legal challenges and diplomatic criticism due to their potential impact on specific populations. Exemptions exist for certain individuals.
-
Helius Medical Technologies Sets Price for $9.1 Million Public Offering
Helius Medical Technologies has priced its public offering, offering 2,768,600 shares of Class A common stock equivalents with warrants for an additional 2,768,600 shares at $3.27 per unit. Warrants have a 2.5-year lifespan and an initial exercise price of $7.35. The offering is expected to close June 6, 2025, with gross proceeds of $9.1 million. Maxim Group LLC is the placement agent.
-
360 Reveals Taiwanese Military’s Cyber Units and Five Major Hacker Groups
A recent report accuses five Taiwanese cyber espionage groups (APT-C-01, 62, 64, 65, and 67) of orchestrating attacks on mainland systems. The report, which directly links these groups to Taiwan’s “Cyber Warfare Unit,” highlights APT-C-67 (Ursula)’s alleged involvement in recent attacks, including targeting critical infrastructure. Experts note the groups utilize known vulnerabilities and rely on less sophisticated techniques, making them easier to detect. The report also highlights broader cyber threats and emphasizes AI’s role in future cybersecurity.
-
Apple to Appeal Rejection of App Store Suspension Request
The Ninth Circuit Court of Appeals denied Apple’s request to stay a lower court order concerning its App Store operations. This ruling impacts Apple’s ability to control in-app purchases by disallowing developers to direct users to external payment options. The ongoing antitrust battle, initiated by Epic Games, is the root of this legal dispute. Apple plans to appeal the decision, disagreeing with the ruling that they violated a previous court order promoting market competition.
-
HUTCHMED and Innovent: China Accepts NDA for Fruquintinib Plus Sintilimab in Advanced Renal Cell Carcinoma
HUTCHMED and Innovent Biologics announced the NMPA acceptance of a New Drug Application for fruquintinib and sintilimab combination therapy. This targets advanced renal cell carcinoma patients who failed prior tyrosine kinase inhibitor treatment. Based on positive FRUSICA-2 trial results, it met its primary endpoint of progression-free survival. The therapy may address the unmet needs for second-line treatment, with ongoing research to expand its applications and indications in immuno-oncology.
-
Americans, Resist! Trump Targets Musk’s Tesla with Devastating Legislation
Elon Musk’s criticism of Republican tax and spending plans has reportedly strained his relationship with Donald Trump. Disagreement over proposed legislation impacting Tesla and the electric vehicle industry, including fees for EV owners and elimination of tax credits, has fueled the tension. Musk, expressing concerns about “debt slavery,” has actively campaigned against the proposals, potentially damaging a previous close collaboration with Trump, who is reportedly displeased with the shift.
-
Targa Resources Corp. Announces $1.5 Billion Senior Notes Offering
Targa Resources Corp. announced a $1.5 billion senior notes offering, comprising notes due 2030 and 2036. Proceeds will redeem existing 2027 notes and be used for general corporate purposes, providing financial flexibility. The offering is under an effective shelf registration with the SEC, and the deal is expected to close June 18, 2025.